News

Quoin Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical stage, specialty pharmaceutical company ...